Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir + adefovir combination salvage therapy in chronic hepatitis B after failure of multiple nucleos(t)ide analogue regimens
ChiCTR-ONC-12002285Phase 4Completed
- Sponsor
- Access to Advanced Health Institute
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of entecavir and adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Access to Advanced Health Institute. Primary endpoints: HBV DNA level, HBeAg seroconversion and 3 more. Started Jun 2011; status: completed.
02
Drugs
entecaviradefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-ONC-12002285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002285.